Scientific research programme has been approved for the period specified below for the purposes of sub-section (2A) of section 35 of the Income-tax Act, 1961 - S.O.1015 - Income Tax Act, 1961
📋
Contents
Cases Cited
Referred In
Notifications
Circulars
Forms
Manuals
Acts
Rules & Regulations
Case Laws New
Ref Provisions New
Plus +
Source NTF
Summary
Similar
Note
Bookmark
Share
✓ Copied successfully !
Print
Print Options
For full text, please login
Login to TaxTMI
Verification Pending
The Email Id has not been verified. Click on the link we have sent on
Scientific research programme approval under section 35(2A): R&D of new drugs at AIIMS sponsored by multiple entities. Approval is granted for an R&D programme on new drugs emphasizing clinical pharmacology and therapeutics, sponsored by multiple private entities and to be conducted at the All India Institute of Medical Sciences, New Delhi, for a five year period commencing in late December 1975, with an estimated expenditure identified; the host institution is recognised as an approved research institution for income tax purposes.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Scientific research programme approval under section 35(2A): R&D of new drugs at AIIMS sponsored by multiple entities.
Approval is granted for an R&D programme on new drugs emphasizing clinical pharmacology and therapeutics, sponsored by multiple private entities and to be conducted at the All India Institute of Medical Sciences, New Delhi, for a five year period commencing in late December 1975, with an estimated expenditure identified; the host institution is recognised as an approved research institution for income tax purposes.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.